Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) Shares Purchased by Charles Schwab Investment Management Inc.
Charles Schwab Investment Management Inc. increased its position in shares of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE – Free Report) by 3.2% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 613,633 shares of the biopharmaceutical company’s stock after acquiring an additional 19,112 […]
Charles Schwab Investment Management Inc. increased its position in shares of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE – Free Report) by 3.2% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 613,633 shares of the biopharmaceutical company’s stock after acquiring an additional 19,112 […]
